Skip to content
drillr.ai
Sign up

ENLV

Enlivex Therapeutics Ltd.

NASDAQ · Healthcare · Biotechnology · IL

$1.11
−4.31%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue—————
Cost of Revenue332.0K332.0K545.0K835.0K777.0K
Gross Profit(332.0K)(332.0K)(545.0K)(835.0K)(777.0K)
Operating Expenses
R&D Expense9.2M8.9M10.1M19.2M18.7M
SG&A Expense5.7M5.7M4.9M6.1M6.7M
General & Admin Expense5.7M5.7M4.9M6.1M6.7M
Selling & Marketing Expense—————
Other Expenses(102.0K)61.0K(48.0K)4.0M402.0K
Total Operating Expenses14.8M14.7M15.0M29.4M25.8M
Cost and Expenses15.0M15.0M15.5M29.4M25.8M
Operating Income (EBIT)(15.0M)(15.0M)(15.5M)(29.4M)(25.8M)
Non-Operating
Interest Income1.9M792.0K1.1M1.6M835.0K
Interest Expense—13.0K13.0K14.0K5.3M
Net Interest Income1.9M779.0K1.1M1.6M(4.4M)
Other Non-Op Income/Expense1.6B1.6B522.0K327.0K(5.3M)
Non-Operating Income (excl Interest)(381.0K)—(522.0K)(341.0K)—
EBT (Pre-Tax Income)1.6B1.6B(15.0M)(29.1M)(31.1M)
Income Tax Expense382.6M382.6M———
Bottom Line
Net Income1.2B1.2B(15.0M)(29.1M)(31.1M)
Earnings from Cont. Ops1.2B1.2B(15.0M)(29.1M)(31.1M)
Earnings from Discont. Ops—————
Bottom Line Net Income1.2B1.2B(15.0M)(29.1M)(31.1M)
Per Share
Basic EPS$405.30$405.60($10.95)($23.40)($34.65)
Diluted EPS$381.90$382.20($10.95)($23.40)($34.65)
Revenue Per Share$0.00$0.00$0.00$0.00$0.00
Shares
Basic Shares Outstanding3.0M3.0M1.4M1.2M1.2M
Diluted Shares Outstanding3.2M3.2M1.4M1.2M1.2M
Profitability Metrics
EBITDA(14.3M)(14.7M)(14.5M)(28.2M)(25.0M)
D&A332.0K332.0K545.0K835.0K777.0K
EBIT(14.6M)(15.0M)(15.0M)(29.1M)(25.8M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Dec 1, 2025